Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7410745rdf:typepubmed:Citationlld:pubmed
pubmed-article:7410745lifeskim:mentionsumls-concept:C0039771lld:lifeskim
pubmed-article:7410745lifeskim:mentionsumls-concept:C0006266lld:lifeskim
pubmed-article:7410745lifeskim:mentionsumls-concept:C0032952lld:lifeskim
pubmed-article:7410745lifeskim:mentionsumls-concept:C0039542lld:lifeskim
pubmed-article:7410745lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:7410745lifeskim:mentionsumls-concept:C0030685lld:lifeskim
pubmed-article:7410745lifeskim:mentionsumls-concept:C0680255lld:lifeskim
pubmed-article:7410745lifeskim:mentionsumls-concept:C0391871lld:lifeskim
pubmed-article:7410745lifeskim:mentionsumls-concept:C1283071lld:lifeskim
pubmed-article:7410745lifeskim:mentionsumls-concept:C1963578lld:lifeskim
pubmed-article:7410745lifeskim:mentionsumls-concept:C0127400lld:lifeskim
pubmed-article:7410745lifeskim:mentionsumls-concept:C1363844lld:lifeskim
pubmed-article:7410745pubmed:issue3lld:pubmed
pubmed-article:7410745pubmed:dateCreated1980-11-20lld:pubmed
pubmed-article:7410745pubmed:abstractTextEleven subjects demonstrating clinical, skin, and inhalation sensitivity to grass or ragweed pollen underwnet serial inhalation challenges, with and without orally administered theophylline, terbutaline, and prednisone. Comparisons of antigen sensitivity and mediator release were made during these challenges. All three drugs significantly reduced antigen sensitivity (PD20 inhalation units increasing from 670 to greater than or equal to 3,280). Peak plasma histamine levels after antigen challenge decreased from 11.4 ng/ml to less than or equal to 3.4 ng/ml during all drug administrations. Similarly, the percent increase in serum neutrophil chemotactic activity (NCA) also decreased, from 96% to less than or equal to 36% during drug administrations. However, even at antigen doses resulting in bronchospasm during drug administration the systemic appearance of NCA and histamine were reduced. We conclude that prednisone, theophylline, and terbutaline significantly reduce antigen-induced bronchospasm and mediator release. The occurrence of bronchospasm despite the inhibition of histamine and NCA suggests either that the local concentration of these mediators are critical or that other mediators produce the bronchospasm observed.lld:pubmed
pubmed-article:7410745pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7410745pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7410745pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7410745pubmed:languageenglld:pubmed
pubmed-article:7410745pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7410745pubmed:citationSubsetAIMlld:pubmed
pubmed-article:7410745pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7410745pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7410745pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7410745pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7410745pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7410745pubmed:statusMEDLINElld:pubmed
pubmed-article:7410745pubmed:monthSeplld:pubmed
pubmed-article:7410745pubmed:issn0091-6749lld:pubmed
pubmed-article:7410745pubmed:authorpubmed-author:ZweimanBBlld:pubmed
pubmed-article:7410745pubmed:authorpubmed-author:DunskyE HEHlld:pubmed
pubmed-article:7410745pubmed:authorpubmed-author:AtkinsP CPClld:pubmed
pubmed-article:7410745pubmed:authorpubmed-author:MartinG LGLlld:pubmed
pubmed-article:7410745pubmed:issnTypePrintlld:pubmed
pubmed-article:7410745pubmed:volume66lld:pubmed
pubmed-article:7410745pubmed:ownerNLMlld:pubmed
pubmed-article:7410745pubmed:authorsCompleteYlld:pubmed
pubmed-article:7410745pubmed:pagination204-12lld:pubmed
pubmed-article:7410745pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:7410745pubmed:meshHeadingpubmed-meshheading:7410745-...lld:pubmed
pubmed-article:7410745pubmed:meshHeadingpubmed-meshheading:7410745-...lld:pubmed
pubmed-article:7410745pubmed:meshHeadingpubmed-meshheading:7410745-...lld:pubmed
pubmed-article:7410745pubmed:meshHeadingpubmed-meshheading:7410745-...lld:pubmed
pubmed-article:7410745pubmed:meshHeadingpubmed-meshheading:7410745-...lld:pubmed
pubmed-article:7410745pubmed:meshHeadingpubmed-meshheading:7410745-...lld:pubmed
pubmed-article:7410745pubmed:meshHeadingpubmed-meshheading:7410745-...lld:pubmed
pubmed-article:7410745pubmed:meshHeadingpubmed-meshheading:7410745-...lld:pubmed
pubmed-article:7410745pubmed:meshHeadingpubmed-meshheading:7410745-...lld:pubmed
pubmed-article:7410745pubmed:meshHeadingpubmed-meshheading:7410745-...lld:pubmed
pubmed-article:7410745pubmed:meshHeadingpubmed-meshheading:7410745-...lld:pubmed
pubmed-article:7410745pubmed:meshHeadingpubmed-meshheading:7410745-...lld:pubmed
pubmed-article:7410745pubmed:meshHeadingpubmed-meshheading:7410745-...lld:pubmed
pubmed-article:7410745pubmed:meshHeadingpubmed-meshheading:7410745-...lld:pubmed
pubmed-article:7410745pubmed:year1980lld:pubmed
pubmed-article:7410745pubmed:articleTitleEffects of theophylline, terbutaline, and prednisone on antigen-induced bronchospasm and mediator release.lld:pubmed
pubmed-article:7410745pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7410745pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:7410745pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:7410745pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7410745lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7410745lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7410745lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7410745lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7410745lld:pubmed